FOXP3 infiltrating lymphocyte density and PD-L1 expression in operable non-small cell lung carcinoma

Giatromanolaki, A; Banham, A; Harris, A; Koukourakis, M

Journal article

FOXP3 infiltrating lymphocyte density and PD-L1 expression in operable non-small cell lung carcinoma

Abstract:: Purpose/Aim: Regulatory FOXP3+ T-cells control the cytotoxic activity of effector cells and may have an essential role in the development of immune tolerance in cancer patients. Programed death ligand 1 PD-L1, expressed on cancer cell membranes also blocks the cytotoxic activity of PD1+ cytotoxic lymphocytes.

Materials and Methods: We assessed the immunohistochemical detection of these immune-tolerance related markers in a series of 98 non-small cell lung carcinomas (NSCLC) treated with surgery. The Tumor Infiltration Lymphocyte TIL density (mean number per x400 optical field) and the percentage of FOXP3+ TILs were assessed.

Results: PD-L1 expression was directly linked with the TIL density (p = 0.01) and with the extent of infiltration with FOXP3+ TILs, named as the FIL-score (p = 0.01). FIL-score was significantly higher in stage I disease (p = 0.04). IL6 expression was linked with high TIL-score. A low TIL-score, characterizing immune deficient tumors defined a significantly poorer prognosis subgroup of patients (p = 0.03). Stratification of these tumors according to the FIL-score showed that FOXP3 expression by TILs correlated with an even a poorer prognosis in univariate (p = 0.007; median survival 14 vs. 44 months, respectively) and in multivariate analysis (p = 0.01, hazard ratio 4.3).

Conclusion: Tumor stroma infiltration by FOXP3+ Tregs is an early event in the progression of NSCLC. Low lymphocytic infiltration defines poor prognosis, which becomes worse when the small numbers of infiltrating lymphocytes characterizing these tumors contain FOXP3 + Tregs. Furthermore, the direct association of FOXP3+ Treg infiltration density with PD-L1 expression by cancer cells implies a co-ordinated immune-suppressive activity in NSCLC.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Giatromanolaki, A., Banham, A., Harris, A., & Koukourakis, M. (2019). FOXP3 infiltrating lymphocyte density and PD-L1 expression in operable non-small cell lung carcinoma. Experimental Lung Research, 45(3-4), 76–83.

MLA Style

Giatromanolaki, A., et al. “FOXP3 Infiltrating Lymphocyte Density and PD-L1 Expression in Operable Non-Small Cell Lung Carcinoma.” Experimental Lung Research, vol. 45, no. 3-4, Taylor and Francis, 2019, pp. 76–83.

Chicago Style

Giatromanolaki, A, A Banham, A Harris, and M Koukourakis. 2019. “FOXP3 Infiltrating Lymphocyte Density and PD-L1 Expression in Operable Non-Small Cell Lung Carcinoma.” Experimental Lung Research 45 (3-4): 76–83.
Share
Print